Delivery Order SPE2DB24D2213-SPE2DB25FGXHT
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,168.96 delivery order for AREXVY vial kits under contract 4568853131 on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement to support federal medical supply requirements. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,707.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for AREXVY VIAL KITS. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC allows Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,693.65 contract is for the delivery of AREXVY VIAL KITS and has an ultimate completion date of June 11, 2025. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AREXVY VIAL KITS. The $2,672.96 award has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this contract. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AREXVY VIAL KITS. The contract has a potential value of $1,707.90 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AREXVY VIAL KITS, with a ceiling value of $7,202.20 and a performance period ending on June 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a large, for-profit organization...
- This federal contract award, valued at $4,462.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AREXVY VIAL KITS. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. This award is not associated with a set-aside program and is part of Amerisourcebergen's broader portfolio of federal contracts, including a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract valued at $5,739.90 to AmerisourceBergen Drug Corp on August 11, 2025, with a completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,216.30 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award represents a pharmaceutical delivery to be...
- SPE2DB24D2213Indefinite Delivery Contract
- SPE2DB24D2213-SPE2DB25FGXHTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AREXVY vial kits, with a ceiling value of $1,440.44. This firm fixed-price delivery order, awarded on July 30, 2025, represents a competitively awarded contract with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling DLA medical supply chain requirements across multiple therapeutic domains, positioning the company as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/30/25 |